Lansforsakringar Fondforvaltning Ab (Publ) Legend Biotech Corp Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $17 Billion
- Q2 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Legend Biotech Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 12,000 shares of LEGN stock, worth $388,439. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000
Previous 27,810
56.85%
Holding current value
$388,439
Previous $943,000
54.93%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60.1MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$224 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$194 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$185 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$122 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$95.9 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.42B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...